Blog List

DIA 2023 – Booth #1138

Booth #1138 – June 26th-28th, 2023 Boston, MAJune 26th-28th, 2023 We’ll be at DIA 2023 in Boston, MA June 26-28. Stop by our booth #1138 to forge new partnerships! The DIA 2023 Global Annual Meeting invites industry, regulatory government, academics, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted […]

Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome

By: Jane Turner1,2, Qianchuan He3, Kelsey Baker1, Lisa Chung4, Adrian Lazarevic-Fogelquist5, Danika Bethune5, Jesse Hubbard1, Margaret Guerriero6, Ajay Sheshadri7, Karen L. Syrjala1,8, Paul J. Martin1,9, Michael Boeckh1,4,10, Stephanie J. Lee1,9, Ted Gooley1, Mary E. Flowers1,9, Guang-Shing Cheng1,6,* 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 2 Division of Respirology, McMaster University, Hamilton, […]

Home-Based Spirometry Telemonitoring After Allogenic Hematopoietic Cell Transplantation

By: Ajay Sheshadri1*, MSc, MD; Sukh Makhnoon2*, MSc, PhD; Amin M Alousi3, MD; Lara Bashoura1, MD; Rene Andrade2, BS; Christopher J Miller2, MPH; Karen R Stolar3, MS; Muhammad Hasan Arain1, MBBS; Laila Noor1, MBBS; Amulya Balagani1, MD; Akash Jain1, MD; David Blanco1, RPFT; Abel Ortiz1, CRT; Michael S Taylor4, BS; Alex Stenzler4, MD; Rohtesh Mehta3, […]

Expanding Dublin-based Company Monitored Therapeutics Inc. Relocates within City

Dublin, OH – January 25th, 2021. A. Kevin Corvo, This Week A Dublin-based company that provides remote patient-monitoring services is expanding its workforce by five-fold at a new location in the city. Monitored Therapeutics Inc. will invest $650,000 as it relocates from Shier Rings Road to 5160 Blazer Parkway. Its first day of operations at the new site […]

Monitored Therapeutics GoSpiro Spirometer Monitors Patients in Pulmotect’s Two Successful COVID- 19 Phase 2 Studies

Dublin, OH – February 14th, 2022. A. Kevin Corvo, This Week Pulmotect, Inc., recently announced results from two Phase 2 clinical trials undertaken to evaluate the inhalation of its PUL-042 immunomodulatory therapy for the prevention and treatment of COVID-19. Results from these trials support the potential of PUL-042 in reducing the severity of COVID-19. Inhaled […]

New Clinical Tool May Better Detect Disease Severity in Patients with Cystic Fibrosis

Mobile app designed to improve access to lung transplant and reduce waitlist mortality In the U.S., individuals are prioritized for life-saving lung transplant by lung allocation score (LAS), which considers both the risk of mortality awaiting transplant and the likelihood of survival after transplant. While lung transplant is a treatment option for patients with advanced […]

Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients

By: Ajay Sheshadri1, Amin Alousi2, Lara Bashoura1, Karen Stolar2, Shiva Baghaie1, Muhammad H. Arain1, Laila Noor1, Amulya Balagani1, Akash Jain1, David Blanco1, Abel Ortiz1, Susan K. Peterson3, Renee Langhals4, Michael Taylor4, Alex Stenzler4, Rohtesh S. Mehta2, Uday R. Popat2, Chitra Hosing2, Gabriela Rondon2, Fan Shen4, Liang Li4, Guang-Shing Cheng6, David E. Ost1, Richard E. Champlin2, […]